Status:
WITHDRAWN
Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization
Lead Sponsor:
Ochsner Health System
Collaborating Sponsors:
Tulane University School of Medicine
GlaxoSmithKline
Conditions:
Methicillin-resistant Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine whether Altabax (retapamulin ointment, 1%) is effective in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization. The hypothes...
Eligibility Criteria
Inclusion
- Subjects must be either a student, resident, or physician at Tulane University or be a resident or physician at Ochsner Medical Center.
Exclusion
- Subjects who are pregnant or who are presently taking antibiotics or require treatment with systemic antibiotics at anytime during the course of the study.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00856089
Start Date
May 1 2009
End Date
October 1 2009
Last Update
September 11 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane University School of Medicine
New Orleans, Louisiana, United States, 70112
2
Ochsner Health System
New Orleans, Louisiana, United States, 70121